Troy Lund

Dr. Lund is an associate professor in the Department of Pediatrics and a faculty member in the Division of Blood and Marrow Transplantation at the University of Minnesota Medical School. He also works as a pediatric blood and marrow transplant physician at the University of Minnesota Masonic Children’s Hospital Pediatric Specialty Care Journey Clinic, specializing in treating adrenoleukodystrophy, leukemia and lymphoma. Dr. Lund’s research interest lies in rare genetic diseases such as the cerebral form of adrenoleukodystrophy (cALD), Hunter syndrome, and Metachromatic Leukodystrophy, the pathophysiological mechanisms of those diseases and the application of hematopoietic stem cell transplantation (HSCT) as a treatment. His particular interest is exploring how an autoimmune reaction may trigger the cALD, the most serious form of adrenoleukodystrophy. He has conducted investigations on one of the largest cohorts of cALD patients who have received HSCT. For his contributions in the medical field, he was recognized as "Top Doctor" in St. Paul Magazine for two consecutive years since 2020. ImStem is currently in collaboration with Dr. Lund on stem cell therapy for cALD.

Dr. Lund obtained his PhD in Cancer Biology from University of South Florida, Moffitt Cancer Centre. Prior to that, he received his MS in Medical Sciences from School of Medicine at the same university. Dr Lund received his MD and subsequently completed residency in Pediatrics and fellowship in Hematology/Oncology and Blood and Marrow Transplantation at University of Minnesota Medical School.